AIG
38
2
DOV
50
2
MAR
60
3
KMB
31
3
DAL
64
3
STX
37
2
AMZN
63
5
WAT
59
4
APH
58
5
MAC
54
3
ACN
54
4
QCOM
59
3
TXT
48
2
MLM
37
2
FOXA
69
5
FAST
44
3
EQIX
59
2
ALLE
25
4
SO
51
3
HOG
29
2
AIG
38
2
DOV
50
2
MAR
60
3
KMB
31
3
DAL
64
3
STX
37
2
AMZN
63
5
WAT
59
4
APH
58
5
MAC
54
3
ACN
54
4
QCOM
59
3
TXT
48
2
MLM
37
2
FOXA
69
5
FAST
44
3
EQIX
59
2
ALLE
25
4
SO
51
3
HOG
29
2
Financhill
Back

Pliant Therapeutics 10K Form

Sell
37

PLRX
Pliant Therapeutics

Last Price:
$13.49
Seasonality Move:
6.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PLRX News And Ratings

See the #1 stock for the next 7 days that we like better than PLRX

PLRX Financial Statistics

Sales & Book Value

Annual Sales: $1.6M
Cash Flow: $-33.2M
Price / Cash Flow: 0
Annual Sales: $5.68
Price / Book: 2.37

Profitability

EPS (TTM): -3.34000
Net Income (TTM): $-201.7M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Pliant Therapeutics Earnings Forecast

Key Pliant Therapeutics Financial Ratios

  • The Research & Development expenses have been 8,088.42% of Revenue.
  • The Interest Expense is -0.79% of Operating Income.
  • The Net Earning history of PLRX is -10,211.14% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Pliant Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: PLRX
CUSIP: 729139
Website: pliantrx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PLRX Technical Analysis vs Fundamental Analysis

Sell
37
Pliant Therapeutics (PLRX) is a Sell

Is Pliant Therapeutics a Buy or a Sell?